Organization

University of Siena

1 clinical trial

2 abstracts

Abstract
Triplet combination treatments with pembrolizumab (pembro) for anti–PD-(L)1–refractory advanced melanoma: Preliminary results of the phase 1/2 KEYMAKER-U02A study.
Org: University Hospital Zurich, Aix-Marseille University CHU Timone, Hôpital de la Timone, Department of Cancer Medicine, Gustave Roussy Cancer Centre, Gustave Roussy Cancer Campus,
Abstract
Breast cancer in patients with Lynch syndrome: A single institution retrospective analysis.
Org: Azienda Ospedaliera Universitaria Senese, Ospedale Biella ASLBI, University of Siena, International Medical University in Rome Unicamillus, Ist Oncol Meidterraneo,